Are the Aging Male's Symptoms (AMS) scale and the Androgen Deficiency in the Aging Male (ADAM) questionnaire suitable for the screening of late-onset hypogonadism in aging Chinese men?

Aging Male

Volumn 16, Issue 3, 2013, Pages 92-96

  Chen, Wei ^a   Liu, Zhi Yong ^a   Wang, Lin Hui ^a   Zeng, Qin Song ^a   Wang, Hui Qing ^a   Sun, Ying Hao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ADAM; AMS; Late onset hypogonadism; Sex hormone

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; AGING MALE'S SYMPTOMS SCALE; ANDROGEN DEFICIENCY IN THE AGING MALE QUESTIONNAIRE; ARTICLE; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QUESTIONNAIRE; RATING SCALE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL;

AGE OF ONSET; AGED; AGING; ANDROGENS; CHINA; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 84883576998     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2013.805319     Document Type: Article

References (24)

1. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91:1995-2010.
2. Nieschlag E, Swerdloff R, Behre HM; International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU), et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 2005;48:1-4.
3. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005;8:56-8.
4. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 2005;28:125-7.
5. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 2006;27:135-7.
6. Heinemann L, Zimmermann T, Vermeulen A, Thiel C. A new "Aging Male's Symptoms" (AMS) rating scale. Aging Male 1999; 2:105-14.
7. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239-42.
8. Morales A, Spevack M, Emerson L, et al. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male 2007;10:57-65.
9. Tancredi A, Reginster JY, Schleich F, et al. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 2004;151:355-60.
10. Beutel ME, Wiltink J; Hypogonadism Investigator Group, et al. Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 2005;47:749-55.
11. Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) 2000; 53:703-11.
12. Corona G, Mannucci E, Petrone L, et al. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 2006;3:706-15.
13. Rosen RC, Araujo AB, Connor MK, et al. The NERI Hypogonadism Screener: psychometric validation in male patients and controls. Clin Endocrinol (Oxf) 2011;74:248-56.
14. Miwa Y, Kaneda T, Yokoyama O. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006;3:723-6.
15. Emmelot-Vonk MH, Verhaar HJ, Nakhai-Pour HR, et al. Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf) 2011;74:488-94.
16. Moore C, Huebler D, Zimmermann T, et al. The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004;46:80-7.
17. Heinemann LA, Moore C, Dinger JC, Stoehr D. Sensitivity as outcome measure of androgen replacement: the AMS scale. Health Qual Life Outcomes 2006;4:23.
18. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98.
19. Blumel JE, Chedraui P, Gili SA, et al. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men? Maturitas 2009;63: 365-8.
20. Basar MM, Aydin G, Mert HC, et al. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology 2005;66:597-601.
21. Morley JE, Perry 3rd HM, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006;53:424-9.
22. Chu LW, Tam S, Kung AW, et al. A short version of the ADAM Questionnaire for androgen deficiency in Chinese men. J Gerontol A Biol Sci Med Sci 2008;63:426-31.
23. Yoshida NM, Kumano H, Kuboki T. Does the Aging Males' Symptoms scale assess major depressive disorder? A pilot study. Maturitas 2006;53:171-5.
24. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72.